Pharma

Your Article Summary

See Latest Articles

HepaLife Acquires Liver Support Technology, Tested in America's Largest-Ever Human Clinical Trial for Bioartificial Liver Assist Devices
Corporate News Releases - The Healthcare Sales & Marketing Network, 10/08/08

HepaLife Technologies, Inc., developers of the first-of-its-kind bioartificial liver device intended for the treatment of human liver failure, announced that the Company has acquired a liver support technology formerly known as "HepatAssist", along with numerous related patents, licenses, clinical protocols, and important fast-track and orphan drug designations by the United States Food and Drug Administration (FDA).

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Berndt Modig appointed as Chief Financial Officer
b3c newswire, 03/19/10

Indias Future as a Biologics Manufacturing Hub
BioPharm, 03/18/10

Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology
Abbott, 03/16/10

 See all of Biotechnology

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

EMIS and CPhA form partnership
Canadian Healthcare Technology, 03/19/10

Maximus acquires Canadian-based Deltaware
Canadian Healthcare Technology, 03/19/10

Teva To Acquire Ratiopharm
Teva Pharmaceutical Industries, 03/19/10

 See all of M&A/Partnerships

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Advisory Panel Unanimously Recommends Expanded Indication for Boston Scientifics Heart Failure Devices Based on Landmark MADIT-CRT Trial
Boston Scientific, 03/19/10

Lubricious coatings from Bayer MaterialScience
BayNews International, 03/19/10

Bayer MaterialScience develops drug-releasing coatings for medical applications
BayNews International, 03/19/10

 See all of Medical Devices/Products